HIV: Single-Tablet Combination Therapy and Patient Weight

hiv single tablet combination therapy and patient weight

Sumary of HIV: Single-Tablet Combination Therapy and Patient Weight:

  • Grace McComsey, MD, FIDSA: Todd, we talked about darunavir, COBI [cobicistat], TAF [tenofovir alafenamide] FDC [fixed-dose combination], a newer, single pill that has a lot of advantages.
  • Whether people are switching, what they’re switching from to an integrase inhibitor, or in trials that have compared integrase inhibitors to other regimens, what the comparison regimen is.
  • Grace McComsey, MD, FIDSA: This potentially provides a non-CNS [central nervous system] toxicity drug with potential benefit of weight gain.
  • John Koethe, MD: Grace, one other thing that will be coming out soon, and what caught the attention of the field in terms of the cobicistat, boosted darunavir with TAF [tenofovir alafenamide] as a potential drug for switch or for prevention of weight gain, was really 2 things.
  • But it’s also lower than the approximately 3 kg that were reported in some of the pooled clinical trials data published in Clinical Infectious Diseases in 2020 for the newer generation integrase inhibitors.

Want to know more click here go to source.

From -


Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.